News
-
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche
Lonza Group AG signs agreement to acquire Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion. Acquisition aims to expand large-scale biologics manufacturing capacity, enhance capabilities, and update sales growth guidance